PortfoliosLab logo
ROG vs. TECH
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between ROG and TECH is 0.40, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.0
Correlation: 0.4

Performance

ROG vs. TECH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Rogers Corporation (ROG) and Bio-Techne Corporation (TECH). The values are adjusted to include any dividend payments, if applicable.

0.00%20,000.00%40,000.00%60,000.00%80,000.00%December2025FebruaryMarchAprilMay
1,060.99%
52,197.15%
ROG
TECH

Key characteristics

Sharpe Ratio

ROG:

-1.26

TECH:

-0.55

Sortino Ratio

ROG:

-1.93

TECH:

-0.61

Omega Ratio

ROG:

0.77

TECH:

0.93

Calmar Ratio

ROG:

-0.59

TECH:

-0.35

Martin Ratio

ROG:

-1.71

TECH:

-1.27

Ulcer Index

ROG:

28.09%

TECH:

17.90%

Daily Std Dev

ROG:

38.16%

TECH:

41.67%

Max Drawdown

ROG:

-80.77%

TECH:

-74.39%

Current Drawdown

ROG:

-76.75%

TECH:

-62.50%

Fundamentals

Market Cap

ROG:

$1.14B

TECH:

$8.03B

EPS

ROG:

$1.40

TECH:

$0.98

PE Ratio

ROG:

44.15

TECH:

51.28

PEG Ratio

ROG:

0.77

TECH:

1.06

PS Ratio

ROG:

1.42

TECH:

6.66

PB Ratio

ROG:

0.88

TECH:

3.84

Total Revenue (TTM)

ROG:

$807.20M

TECH:

$892.59M

Gross Profit (TTM)

ROG:

$265.90M

TECH:

$581.78M

EBITDA (TTM)

ROG:

$61.90M

TECH:

$242.73M

Returns By Period

In the year-to-date period, ROG achieves a -37.31% return, which is significantly lower than TECH's -31.02% return. Over the past 10 years, ROG has underperformed TECH with an annualized return of -1.50%, while TECH has yielded a comparatively higher 8.26% annualized return.


ROG

YTD

-37.31%

1M

-5.22%

6M

-36.48%

1Y

-46.30%

5Y*

-10.11%

10Y*

-1.50%

TECH

YTD

-31.02%

1M

-13.46%

6M

-32.55%

1Y

-32.15%

5Y*

-2.24%

10Y*

8.26%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

ROG vs. TECH — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ROG
The Risk-Adjusted Performance Rank of ROG is 55
Overall Rank
The Sharpe Ratio Rank of ROG is 11
Sharpe Ratio Rank
The Sortino Ratio Rank of ROG is 33
Sortino Ratio Rank
The Omega Ratio Rank of ROG is 44
Omega Ratio Rank
The Calmar Ratio Rank of ROG is 1414
Calmar Ratio Rank
The Martin Ratio Rank of ROG is 44
Martin Ratio Rank

TECH
The Risk-Adjusted Performance Rank of TECH is 2222
Overall Rank
The Sharpe Ratio Rank of TECH is 2222
Sharpe Ratio Rank
The Sortino Ratio Rank of TECH is 2121
Sortino Ratio Rank
The Omega Ratio Rank of TECH is 2222
Omega Ratio Rank
The Calmar Ratio Rank of TECH is 2929
Calmar Ratio Rank
The Martin Ratio Rank of TECH is 1717
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

ROG vs. TECH - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Rogers Corporation (ROG) and Bio-Techne Corporation (TECH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for ROG, currently valued at -1.26, compared to the broader market-2.00-1.000.001.002.003.00
ROG: -1.26
TECH: -0.55
The chart of Sortino ratio for ROG, currently valued at -1.93, compared to the broader market-6.00-4.00-2.000.002.004.00
ROG: -1.93
TECH: -0.61
The chart of Omega ratio for ROG, currently valued at 0.77, compared to the broader market0.501.001.502.00
ROG: 0.77
TECH: 0.93
The chart of Calmar ratio for ROG, currently valued at -0.59, compared to the broader market0.001.002.003.004.005.00
ROG: -0.59
TECH: -0.35
The chart of Martin ratio for ROG, currently valued at -1.71, compared to the broader market-10.000.0010.0020.00
ROG: -1.71
TECH: -1.27

The current ROG Sharpe Ratio is -1.26, which is lower than the TECH Sharpe Ratio of -0.55. The chart below compares the historical Sharpe Ratios of ROG and TECH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.00December2025FebruaryMarchAprilMay
-1.26
-0.55
ROG
TECH

Dividends

ROG vs. TECH - Dividend Comparison

ROG has not paid dividends to shareholders, while TECH's dividend yield for the trailing twelve months is around 0.64%.


TTM20242023202220212020201920182017201620152014
ROG
Rogers Corporation
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
TECH
Bio-Techne Corporation
0.64%0.44%0.41%0.77%0.25%0.40%0.58%0.88%0.99%1.24%1.42%1.35%

Drawdowns

ROG vs. TECH - Drawdown Comparison

The maximum ROG drawdown since its inception was -80.77%, which is greater than TECH's maximum drawdown of -74.39%. Use the drawdown chart below to compare losses from any high point for ROG and TECH. For additional features, visit the drawdowns tool.


-80.00%-70.00%-60.00%-50.00%-40.00%December2025FebruaryMarchAprilMay
-76.75%
-62.50%
ROG
TECH

Volatility

ROG vs. TECH - Volatility Comparison

Rogers Corporation (ROG) has a higher volatility of 22.27% compared to Bio-Techne Corporation (TECH) at 19.91%. This indicates that ROG's price experiences larger fluctuations and is considered to be riskier than TECH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%December2025FebruaryMarchAprilMay
22.27%
19.91%
ROG
TECH

Financials

ROG vs. TECH - Financials Comparison

This section allows you to compare key financial metrics between Rogers Corporation and Bio-Techne Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


180.00M200.00M220.00M240.00M260.00M280.00M300.00M20212022202320242025
190.50M
297.03M
(ROG) Total Revenue
(TECH) Total Revenue
Values in USD except per share items

ROG vs. TECH - Profitability Comparison

The chart below illustrates the profitability comparison between Rogers Corporation and Bio-Techne Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

30.0%40.0%50.0%60.0%70.0%20212022202320242025
29.9%
65.3%
(ROG) Gross Margin
(TECH) Gross Margin
ROG - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Rogers Corporation reported a gross profit of 57.00M and revenue of 190.50M. Therefore, the gross margin over that period was 29.9%.
TECH - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Bio-Techne Corporation reported a gross profit of 193.89M and revenue of 297.03M. Therefore, the gross margin over that period was 65.3%.
ROG - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Rogers Corporation reported an operating income of -300.00K and revenue of 190.50M, resulting in an operating margin of -0.2%.
TECH - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Bio-Techne Corporation reported an operating income of 47.42M and revenue of 297.03M, resulting in an operating margin of 16.0%.
ROG - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Rogers Corporation reported a net income of -1.40M and revenue of 190.50M, resulting in a net margin of -0.7%.
TECH - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Bio-Techne Corporation reported a net income of 34.89M and revenue of 297.03M, resulting in a net margin of 11.8%.